Qelbree Capsule, Extended Release
Product Images NDC 17772-133

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Qelbree (NDC 17772-133). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Supernus Pharmaceuticals, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Qelbree 01)

FDA Label Image

Figure 1 (Qelbree 02)

Figure 1 (Qelbree 02)
This text is a table showing various levels of hepatic and renal impairment and their effect on pharmacokinetics (PK). The table lists parameters like Cmax and auc, and demonstrates fold change and 90% confidence intervals for each level of impairment. It appears to be related to drug dosing in special populations.*
FDA Label Image

Figure 2 (Qelbree 03)

FDA Label Image

Figure 3 (Qelbree 04)

FDA Label Image

Principal Display Panel (100 mg Capsule Bottle Label)

Principal Display Panel (100 mg Capsule Bottle Label)
This is a description for a medication called Qelbree, which comes in the form of extended-release capsules. The recommended dosage is once daily and it is taken orally. The bottle contains 30 capsules and can be identified by the NDC number 17772-131-30. Instructions to dispense the accompanying medication guide to each patient is a requirement.*
FDA Label Image

Principal Display Panel (150 mg Capsule Bottle Label)

Principal Display Panel (150 mg Capsule Bottle Label)
This seems to be a description of a medication called Qelbree in the form of extended-release capsules. It comes in a package containing 30 capsules with the NDC code 17772-132-30. The medication is taken orally once daily and is accompanied by a medication guide that should be given to each patient by the dispensing pharmacist. The remaining text consists of a code and some symbols.*
FDA Label Image

Principal Display Panel (200 mg Capsule Bottle Label)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.